The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience

Background. Infliximab (IFX) therapeutic drug monitoring (TDM) allows for objective decision making in patients with inflammatory bowel disease (IBD) and loss of response. Questions remain about whether IFX TDM improves outcomes. Methods. Patients with IBD who had IFX TDM due to concerns for loss of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Robert A., Shuster, Constantin, Shahidi, Neal, Galorport, Cherry, DeMarco, Mari L., Rosenfeld, Gregory, Enns, Robert A., Bressler, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121455/
https://www.ncbi.nlm.nih.gov/pubmed/27957480
http://dx.doi.org/10.1155/2016/5203898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121455/
https://www.ncbi.nlm.nih.gov/pubmed/27957480
http://dx.doi.org/10.1155/2016/5203898

Ejemplares similares